JOHN NIELSEN: Open Payments
NPI 1477965275 · WEST JORDAN, UT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,413 in 67 payments from 15 companies in 2025. Trend: 2023 $1,456 · 2024 $1,279 · 2025 $1,413
Food & beverage: $1,413
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 15 | $371 |
| ABBVIE INC. | 11 | $183 |
| Alkermes, Inc. | 7 | $135 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $121 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $92 |
| Otsuka America Pharmaceutical, Inc. | 5 | $92 |
| Axsome Therapeutics, Inc. | 4 | $80 |
| Lilly USA, LLC | 4 | $69 |
| PFIZER INC. | 4 | $63 |
| Astellas Pharma US Inc | 2 | $50 |
Products named: AIRSUPRA, BREZTRI, LYBALVI, CAPLYTA, Kerendia, REXULTI, QULIPTA, NURTEC ODT.
Industry payments across UT — which companies pay providers there.
